ambasilide has been researched along with Atrial Fibrillation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, J; Nattel, S; Wang, J | 1 |
| Bianconi, L; Castro, A; Santini, M | 1 |
1 review(s) available for ambasilide and Atrial Fibrillation
| Article | Year |
|---|---|
New antiarrhythmic drugs for the treatment of atrial fibrillation.
Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2002 |
1 other study(ies) available for ambasilide and Atrial Fibrillation
| Article | Year |
|---|---|
Class III antiarrhythmic drug action in experimental atrial fibrillation. Differences in reverse use dependence and effectiveness between d-sotalol and the new antiarrhythmic drug ambasilide.
Topics: Aminobenzoates; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Chronic Disease; Dogs; Female; Male; Neural Conduction; Pericarditis; Refractory Period, Electrophysiological; Sotalol; Vagus Nerve | 1994 |